• Late-stage clinical failures due to a lack of efficacy or due to clinical safety issues are a major impediment to efficient and cost-effective drug development.
• Early in-depth profiling of lead candidates or drugs in preclinical development can help to reduce the risks of failure.
• Take advantage of our drug profiling and target profiling services to get important information on the property of your lead candidates, their target and off-target spectrum and potential issues related to toxicity and efficacy.

• Profile your drug to identify targets and to learn more about its mechanism of action
• Identify off-target effects and corresponding toxicity issues early in development
• Get timely information on additional, unknown targets for your drug under development to enable efficient repositioning to alternative indications
• Learn more about the association of your drug targets with other proteins and the signalling and metabolic pathways involved
• Get insight into affected pathways and potential toxicity effects

Learn more about our drug profiling service